Repligen (RGEN) Other Non-Current Assets (2011 - 2026)
Repligen's (RGEN) quarterly Other Non-Current Assets came in at $4.0 million in Q2 2026, up 57.61% year-over-year from $2.6 million in Q2 2025, and down 31.17% quarter-over-quarter from $5.9 million in Q1 2026.
Analysis
Repligen (RGEN) Other Non-Current Assets (2011 - 2026) Analysis & Trends
Repligen (RGEN) has reported Other Non-Current Assets for 16 consecutive years, with $4.0 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Other Non-Current Assets rose 57.61% year-over-year to $4.0 million in Q2 2026; TTM through Jun 2026 was $4.0 million, a 57.61% increase from a year earlier, with the FY2025 full-year figure at $4.9 million, up 466.01% from the prior year.
- Other Non-Current Assets was $4.0 million for Q2 2026 at Repligen, down from $5.9 million in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $5.9 million in Q1 2026 and troughed at $631000.0 in Q1 2022.
- A 5-year average of $2.0 million and a median of $1.2 million in 2023 frame the typical range for Other Non-Current Assets.
- Across the five-year window, Other Non-Current Assets tumbled 48.2% in 2024 and surged 582.49% in 2025, its largest moves.
- Over 5 years, Other Non-Current Assets stood at $815000.0 in 2022, then jumped by 56.69% to $1.3 million in 2023, then tumbled by 32.03% to $868000.0 in 2024, then jumped by 466.01% to $4.9 million in 2025, then declined by 17.59% to $4.0 million in 2026.
- The last three Other Non-Current Assets figures came in at $4.0 million (Q2 2026), $5.9 million (Q1 2026), and $4.9 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn | 5.62 Bn |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn | 4.39 Bn |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn | 1.07 Bn |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn | 576.00 Mn |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn | 309.11 Mn |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn | 264.34 Mn |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn | 101.70 Mn |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn | 4.05 Mn |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn | 15.31 Mn |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn | 816.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.05 Mn |
| Mar 31, 2026 | 5.88 Mn |
| Dec 31, 2025 | 4.91 Mn |
| Sep 30, 2025 | 5.11 Mn |
| Jun 30, 2025 | 2.57 Mn |
| Mar 31, 2025 | 2.11 Mn |
| Dec 31, 2024 | 868,000.00 |
| Sep 30, 2024 | 748,000.00 |
| Jun 30, 2024 | 1.00 Mn |
| Mar 31, 2024 | 1.00 Mn |
| Dec 31, 2023 | 1.28 Mn |
| Sep 30, 2023 | 1.44 Mn |
| Jun 30, 2023 | 1.66 Mn |
| Mar 31, 2023 | 1.19 Mn |
| Dec 31, 2022 | 815,000.00 |
| Sep 30, 2022 | 800,000.00 |
| Jun 30, 2022 | 769,000.00 |
| Mar 31, 2022 | 631,000.00 |
| Dec 31, 2021 | 615,000.00 |
| Sep 30, 2021 | 620,000.00 |